Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis

Molecular Carcinogenesis

Volumn 24, Issue 4, 1999, Pages 241-245

  Zongjian, Zhu ^a   Jiang, Weiqin ^a   Thompson, Henry J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cell cycle progression; Cyclin D1; Energy restriction; Mammary carcinogenesis; p27 kip1

Indexed keywords

CYCLIN D1; METHYLNITROSOUREA; PHOSPHOTRANSFERASE; PROTEIN P27; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA IN SITU; CELL CYCLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENOCARCINOMA; ANIMALS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; FOOD DEPRIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEINS;

EID: 0344416982     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199904)24:4<241::AID-MC1>3.0.CO;2-P     Document Type: Article

References (20)

1. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Adv Exp Med Biol 1992;322:134-141.
2. Weindruch R, Walford RL. The retardation of aging and disease by dietary restriction. Springfield, IL: Charles C. Thomas, Publisher; 1988.
3. Masoro EJ. Dietary restriction. Exp Gerontol 1995;30:291-298.
4. Kritchevsky D. Diet in heart disease and cancer. Adv Exp Med Biol 1995;369:201-209.
5. Zhu Z, Haegele A, Thompson HJ. Effect of caloric restriction on premalignant and malignant stages of mammary carcinogenesis. Carcinogenesis 1997;18:1007-1012.
6. Strack AM, Sebastian RJ, Schwartz MW, Dallman MF. Glucocorticoids and insulin: Reciprocal signals for energy balance. Am J Physiol 1995;268:R142-R149.
7. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-1677.
8. Thompson HJ, McGinley JN, Rothhammer K, Singh M. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 1995;16: 2407-2411.
9. Russo J, Russo IH, Rogers AE, VanZwieten MJ, Gusterson B. Tumors of the mammary gland. IARC Sci Publ 1990;99:47-78.
10. Bacus JW, Grace LJ. Optical microscope system for standardized cell measurements and analyses. Applied Optics 1987;26:3280-3293.
11. Kruskal WH, Wallis WA. Use of ranks in one criterion variance analysis. Journal of the American Statistical Association 1952;47:583-621.
12. Rogatsky I, Trowbridge JM, Garabedian MJ. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol 17;3181-3193, 1997.
13. Hengst L, Reed SI. Translational control of p27Kip1 accumulation during the cell cycle. Science 1996;271:1861-1864.
14. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85:707-720.
15. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996;85:721-732.
16. Thompson HJ, Strange R, Schedin PJ. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prev 1992;1:597-602.
17. Steel GG. Growth rate of tumors. In: Steel GG, editor. Growth kinetics of tumors. Oxford: Clarendon Press; 1977. p 6-
18. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
19. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 eyelid-dependent kinases. Genes Dev 1995;9:1149-1163.
20. Fredersdorf S, Burns J, Milne AM, et al. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997;94:6380-6385.